New investors Abingworth, MVM co-lead $40mm Series B for Wilson Therapeutics
- Specialty Pharmaceuticals
- Private Placement
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.